Treatment Resistant Depression Market – Neuromodulation Advances
Market Overview The treatment resistant depression market is being transformed by advances in neuromodulation, including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and deep brain stimulation (DBS). These technologies offer non-pharmacological options for patients with TRD. The market is projected to grow through 2030, driven by...
0 Σχόλια 0 Μοιράστηκε 30 Views 0 Προεπισκόπηση